請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/90353完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳明汝 | zh_TW |
| dc.contributor.advisor | Ming-Ju Chen | en |
| dc.contributor.author | 水修禹 | zh_TW |
| dc.contributor.author | Hsiu-Yu Shui | en |
| dc.date.accessioned | 2023-09-27T16:08:49Z | - |
| dc.date.available | 2023-11-10 | - |
| dc.date.copyright | 2023-09-27 | - |
| dc.date.issued | 2023 | - |
| dc.date.submitted | 2023-07-26 | - |
| dc.identifier.citation | Ahmed, W., Dewar, S., Williams, R., Stansby, G., Harris, K., & Weiand, D. (2021). Lawsonella clevelandensis is a rare cause of infected chronic contained rupture of abdominal aortic aneurysm. Access Microbiol, 3(1), acmi000183. https://doi.org/10.1099/acmi.0.000183
Alam, M. J., Xie, L., Yap, Y. A., Marques, F. Z., & Robert, R. (2022). Manipulating Microbiota to Treat Atopic Dermatitis: Functions and Therapies. Pathogens, 11(6). https://doi.org/10.3390/pathogens11060642 Ashley, E. A. (2016). Towards precision medicine. Nat Rev Genet, 17(9), 507-522. https://doi.org/10.1038/nrg.2016.86 Bando, H. (2017). The current status and problems confronted in delivering precision medicine in Japan and Europe. Curr Probl Cancer, 41(3), 166-175. https://doi.org/10.1016/j.currproblcancer.2017.02.003 Chen, H. Y., Chen, Y. T., Li, K. Y., Huang, H. W., Lin, Y. C., & Chen, M. J. (2022). A Heat-Killed Probiotic Mixture Regulates Immune T Cells Balance and IgE Production in House Dust Mite Extraction-Induced Atopic Dermatitis Mice. Microorganisms, 10(10). https://doi.org/10.3390/microorganisms10101881 Darby, T. M., Owens, J. A., Saeedi, B. J., Luo, L., Matthews, J. D., Robinson, B. S., Naudin, C. R., & Jones, R. M. (2019). Lactococcus Lactis Subsp. cremoris Is an Efficacious Beneficial Bacterium that Limits Tissue Injury in the Intestine. iScience, 12, 356-367. https://doi.org/10.1016/j.isci.2019.01.030 Eichenfield, L. F., Ahluwalia, J., Waldman, A., Borok, J., Udkoff, J., & Boguniewicz, M. (2017). Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol, 139(4S), S49-S57. https://doi.org/10.1016/j.jaci.2017.01.009 Fang, Z., Li, L., Zhang, H., Zhao, J., Lu, W., & Chen, W. (2021). Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review. Front Immunol, 12, 720393. https://doi.org/10.3389/fimmu.2021.720393 Favrot, C., Steffan, J., Seewald, W., & Picco, F. (2010). A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol, 21(1), 23-31. https://doi.org/10.1111/j.1365-3164.2009.00758.x Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., Ashworth, A., Carmichael, J., Kaye, S. B., Schellens, J. H., & de Bono, J. S. (2009). Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med, 361(2), 123-134. https://doi.org/10.1056/NEJMoa0900212 Gedon, N. K. Y., & Mueller, R. S. (2018). Atopic dermatitis in cats and dogs: a difficult disease for animals and owners. Clin Transl Allergy, 8, 41. https://doi.org/10.1186/s13601-018-0228-5 Gotoh, Y., Suzuki, S., Amako, M., Kitamura, S., & Toda, T. (2017). Effect of orally administered exopolysaccharides produced by Lactococcus lactis subsp. cremoris FC on a mouse model of dermatitis induced by repeated exposure to 2,4,6-trinitro-1-chlorobenzene. Journal of Functional Foods, 35, 43-50. https://doi.org/10.1016/j.jff.2017.04.045 Harb, H., & Chatila, T. A. (2020). Mechanisms of Dupilumab. Clin Exp Allergy, 50(1), 5-14. https://doi.org/10.1111/cea.13491 Hasan, N., & Yang, H. (2019). Factors affecting the composition of the gut microbiota, and its modulation. PeerJ, 7, e7502. https://doi.org/10.7717/peerj.7502 He, L., Yang, F. Q., Tang, P., Gao, T. H., Yang, C. X., Tan, L., Yue, P., Hua, Y. N., Liu, S. J., & Guo, J. L. (2022). Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus. Biomed Pharmacother, 151, 113091. https://doi.org/10.1016/j.biopha.2022.113091 Hill, P. B., Lau, P., & Rybnicek, J. (2007). Development of an owner-assessed scale to measure the severity of pruritus in dogs. Vet Dermatol, 18(5), 301-308. https://doi.org/10.1111/j.1365-3164.2007.00616.x Hovelson, D. H., McDaniel, A. S., Cani, A. K., Johnson, B., Rhodes, K., Williams, P. D., Bandla, S., Bien, G., Choppa, P., Hyland, F., Gottimukkala, R., Liu, G., Manivannan, M., Schageman, J., Ballesteros-Villagrana, E., Grasso, C. S., Quist, M. J., Yadati, V., Amin, A., . . . Tomlins, S. A. (2015). Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors. Neoplasia, 17(4), 385-399. https://doi.org/10.1016/j.neo.2015.03.004 Institute of Biomedical Sciences, A. S. (2020). Taiwan Precision Medicine Initiative. https://tpmi.ibms.sinica.edu.tw/www/en/ Jennison, A. V., & Verma, N. K. (2004). Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microbiol Rev, 28(1), 43-58. https://doi.org/10.1016/j.femsre.2003.07.002 Keam, S. J. (2022). Nemolizumab: First Approval. Drugs, 82(10), 1143-1150. https://doi.org/10.1007/s40265-022-01741-z Kim, J. H., Kim, K., & Kim, W. (2021). Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy. Exp Mol Med, 53(5), 907-916. https://doi.org/10.1038/s12276-021-00627-6 Kim, W. K., Jang, Y. J., Han, D. H., Jeon, K., Lee, C., Han, H. S., & Ko, G. (2020). Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota. Gut Microbes, 12(1), 1-14. https://doi.org/10.1080/19490976.2020.1819156 Lancet, T. (2021). 20 years of precision medicine in oncology. The Lancet, 397(10287), 1781. https://doi.org/https://doi.org/10.1016/S0140-6736(21)01099-0 Langan, S. M., Irvine, A. D., & Weidinger, S. (2020). Atopic dermatitis. Lancet, 396(10247), 345-360. https://doi.org/10.1016/S0140-6736(20)31286-1 Lee, P., Yacyshyn, B. R., & Yacyshyn, M. B. (2019). Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT). Diabetes Obes Metab, 21(3), 479-490. https://doi.org/10.1111/dom.13561 Leo, S., Cetiner, O. F., Pittet, L. F., Messina, N. L., Jakob, W., Falquet, L., Curtis, N., & Zimmermann, P. (2023). The association between the composition of the early-life intestinal microbiome and eczema in the first year of life. Frontiers in Microbiomes, 2. https://doi.org/10.3389/frmbi.2023.1147082 Levy, Y. (2016). Genomic medicine 2025: France in the race for precision medicine. Lancet, 388(10062), 2872. https://doi.org/10.1016/S0140-6736(16)32467-9 Li, A. W., Yin, E. S., & Antaya, R. J. (2017). Topical Corticosteroid Phobia in Atopic Dermatitis: A Systematic Review. JAMA Dermatol, 153(10), 1036-1042. https://doi.org/10.1001/jamadermatol.2017.2437 Liu, X., Mao, B., Gu, J., Wu, J., Cui, S., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2021). Blautia-a new functional genus with potential probiotic properties? Gut Microbes, 13(1), 1-21. https://doi.org/10.1080/19490976.2021.1875796 Marsella, R., & Girolomoni, G. (2009). Canine models of atopic dermatitis: a useful tool with untapped potential. J Invest Dermatol, 129(10), 2351-2357. https://doi.org/10.1038/jid.2009.98 Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M. L., Luke, J. J., & Gajewski, T. F. (2018). The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science, 359(6371), 104-108. https://doi.org/10.1126/science.aao3290 Milosavljevic, M. N., Kostic, M., Milovanovic, J., Zaric, R. Z., Stojadinovic, M., Jankovic, S. M., & Stefanovic, S. M. (2021). Antimicrobial treatment of Erysipelatoclostridium ramosum invasive infections: a systematic review. Rev Inst Med Trop Sao Paulo, 63, e30. https://doi.org/10.1590/S1678-9946202163030 Mineshige, T., Kamiie, J., Sugahara, G., & Shirota, K. (2018). A study on periostin involvement in the pathophysiology of canine atopic skin. J Vet Med Sci, 80(1), 103-111. https://doi.org/10.1292/jvms.17-0453 Montano-Samaniego, M., Bravo-Estupinan, D. M., Mendez-Guerrero, O., Alarcon-Hernandez, E., & Ibanez-Hernandez, M. (2020). Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Front Oncol, 10, 605380. https://doi.org/10.3389/fonc.2020.605380 National Academies of Sciences, E., & Medicine. (2016). Biomarker tests for molecularly targeted therapies: key to unlocking precision medicine. National Institutes of Health, N. (2023, February 28, 2023). Pharmacogenomics. https://www.nih.gov/about-nih/what-we-do/nih-turning-discovery-into-health/pharmacogenomics Negroni, A., Pierdomenico, M., Cucchiara, S., & Stronati, L. (2018). NOD2 and inflammation: current insights. J Inflamm Res, 11, 49-60. https://doi.org/10.2147/JIR.S137606 Olivry, T., Saridomichelakis, M., Nuttall, T., Bensignor, E., Griffin, C. E., Hill, P. B., & International Committe on Allergic Diseases of, A. (2014). Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs. Vet Dermatol, 25(2), 77-85, e25. https://doi.org/10.1111/vde.12107 Park, B. O., Kang, J. S., Paudel, S., Park, S. G., Park, B. C., Han, S. B., Kwak, Y. S., Kim, J. H., & Kim, S. (2022). Novel GPR43 Agonists Exert an Anti-Inflammatory Effect in a Colitis Model. Biomol Ther (Seoul), 30(1), 48-54. https://doi.org/10.4062/biomolther.2021.078 Patel, N. U., D'Ambra, V., & Feldman, S. R. (2017). Increasing Adherence with Topical Agents for Atopic Dermatitis. Am J Clin Dermatol, 18(3), 323-332. https://doi.org/10.1007/s40257-017-0261-5 Petersen, E. B. M., Skov, L., Thyssen, J. P., & Jensen, P. (2019). Role of the Gut Microbiota in Atopic Dermatitis: A Systematic Review. Acta Derm Venereol, 99(1), 5-11. https://doi.org/10.2340/00015555-3008 Petrosino, J. F. (2018). The microbiome in precision medicine: the way forward. Genome Med, 10(1), 12. https://doi.org/10.1186/s13073-018-0525-6 Phillips, C. J. (2020). Precision Medicine and its Imprecise History. Harvard Data Science Review. https://doi.org/10.1162/99608f92.3e85b56a Plassart, C., Mauvais, F., Heurte, J., Sautereau, J., Legeay, C., & Bouvet, P. (2013). First case of intra-abdominal infection with Clostridium disporicum. Anaerobe, 19, 77-78. https://doi.org/10.1016/j.anaerobe.2012.12.002 Prasad, R. B., & Groop, L. (2019). Precision medicine in type 2 diabetes. J Intern Med, 285(1), 40-48. https://doi.org/10.1111/joim.12859 Proell, M., Riedl, S. J., Fritz, J. H., Rojas, A. M., & Schwarzenbacher, R. (2008). The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One, 3(4), e2119. https://doi.org/10.1371/journal.pone.0002119 Ramesh, R., Assi, M., Esquer Garrigos, Z., & Sohail, M. R. (2021). Lawsonella clevelandensis: an emerging cause of vascular graft infection. BMJ Case Rep, 14(2). https://doi.org/10.1136/bcr-2020-237350 Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., Fidelle, M., Flament, C., Poirier-Colame, V., Opolon, P., Klein, C., Iribarren, K., Mondragón, L., Jacquelot, N., Qu, B., . . . Zitvogel, L. (2018). Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science, 359(6371), 91-97. https://doi.org/10.1126/science.aan3706 Rybnicek, J., Lau-Gillard, P. J., Harvey, R., & Hill, P. B. (2009). Further validation of a pruritus severity scale for use in dogs. Vet Dermatol, 20(2), 115-122. https://doi.org/10.1111/j.1365-3164.2008.00728.x Serdar, C. C., Cihan, M., Yucel, D., & Serdar, M. A. (2021). Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb), 31(1), 010502. https://doi.org/10.11613/BM.2021.010502 Shin, N. R., Kang, W., Tak, E. J., Hyun, D. W., Kim, P. S., Kim, H. S., Lee, J. Y., Sung, H., Whon, T. W., & Bae, J. W. (2018). Blautia hominis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol, 68(4), 1059-1064. https://doi.org/10.1099/ijsem.0.002623 Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014). The role of short-chain fatty acids in health and disease. Adv Immunol, 121, 91-119. https://doi.org/10.1016/B978-0-12-800100-4.00003-9 Tanprasertsuk, J., Jha, A. R., Shmalberg, J., Jones, R. B., Perry, L. M., Maughan, H., & Honaker, R. W. (2021). The microbiota of healthy dogs demonstrates individualized responses to synbiotic supplementation in a randomized controlled trial. Anim Microbiome, 3(1), 36. https://doi.org/10.1186/s42523-021-00098-0 Tier, H. L., Balogh, E. A., Bashyam, A. M., Fleischer, A. B., Jr., Spergel, J. M., Masicampo, E. J., Kammrath, L. K., Strowd, L. C., & Feldman, S. R. (2021). Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review. Dermatol Ther (Heidelb), 11(2), 415-431. https://doi.org/10.1007/s13555-021-00500-4 Turpin, W., Bedrani, L., Espin-Garcia, O., Xu, W., Silverberg, M. S., Smith, M. I., Garay, J. A. R., Lee, S. H., Guttman, D. S., Griffiths, A., Moayyedi, P., Panaccione, R., Huynh, H., Steinhart, H. A., Aumais, G., Dieleman, L. A., Turner, D., team, C. I. G. P. r., Paterson, A. D., & Croitoru, K. (2020). Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects. BMC Med Genet, 21(1), 204. https://doi.org/10.1186/s12881-020-01115-w Udkoff, J., Waldman, A., Ahluwalia, J., Borok, J., & Eichenfield, L. F. (2017). Current and emerging topical therapies for atopic dermatitis. Clin Dermatol, 35(4), 375-382. https://doi.org/10.1016/j.clindermatol.2017.03.010 Wang, R., Nakajima-Adachi, H., Wang, Y., Zhou, Y., Gu, W., Hiraide, E., Morinaga, M., Nakagawa, R., Nakamura, S., Takano, T., Li, X., Saeki, M., Kaminuma, O., Hiroi, T., Uchida, K., Motoshima, H., Tanokura, M., Miyakawa, T., & Hachimura, S. (2022). Regulation of Th2 responses by Lactococcus lactis subsp. cremoris YRC3780 alleviates DNCB-induced atopic dermatitis in the mouse model. Journal of Functional Foods, 94. https://doi.org/10.1016/j.jff.2022.105091 Wang, X., Liang, Z., Wang, S., Ma, D., Zhu, M., & Feng, J. (2022). Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications. Curr Neuropharmacol, 20(7), 1413-1426. https://doi.org/10.2174/1570159X19666210629145351 Wollenberg, A., Barbarot, S., Bieber, T., Christen-Zaech, S., Deleuran, M., Fink-Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., Czarnecka-Operacz, M., Schafer, T., Schmid-Grendelmeier, P., Simon, D., Szalai, Z., Szepietowski, J. C., Taieb, A., Torrelo, A., Werfel, T., . . . the European Union of Medical, S. (2018). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol, 32(6), 850-878. https://doi.org/10.1111/jdv.14888 Wu, W., Sun, M., Chen, F., Cao, A. T., Liu, H., Zhao, Y., Huang, X., Xiao, Y., Yao, S., Zhao, Q., Liu, Z., & Cong, Y. (2017). Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunol, 10(4), 946-956. https://doi.org/10.1038/mi.2016.114 Yaneva, M., & Darlenski, R. (2021). The link between atopic dermatitis and asthma- immunological imbalance and beyond. Asthma Res Pract, 7(1), 16. https://doi.org/10.1186/s40733-021-00082-0 Yoshimatsu, Y., Mikami, Y., & Kanai, T. (2021). Bacteriotherapy for inflammatory bowel disease. Inflamm Regen, 41(1), 3. https://doi.org/10.1186/s41232-020-00153-4 Yosipovitch, G., & Papoiu, A. D. P. (2008). What causes itch in atopic dermatitis? Current Allergy and Asthma Reports, 8(4), 306-311. https://doi.org/10.1007/s11882-008-0049-z Zakham, F., Pillonel, T., Brunel, A. S., Zambelli, P. Y., Greub, G., Croxatto, A., & Bertelli, C. (2019). Molecular diagnosis and enrichment culture identified a septic pseudoarthrosis due to an infection with Erysipelatoclostridium ramosum. Int J Infect Dis, 81, 167-169. https://doi.org/10.1016/j.ijid.2019.02.001 Zhang, Z., Zhang, H., Chen, T., Shi, L., Wang, D., & Tang, D. (2022). Regulatory role of short-chain fatty acids in inflammatory bowel disease. Cell Commun Signal, 20(1), 64. https://doi.org/10.1186/s12964-022-00869-5 Zhu, W., Winter, M. G., Byndloss, M. X., Spiga, L., Duerkop, B. A., Hughes, E. R., Buttner, L., de Lima Romao, E., Behrendt, C. L., Lopez, C. A., Sifuentes-Dominguez, L., Huff-Hardy, K., Wilson, R. P., Gillis, C. C., Tukel, C., Koh, A. Y., Burstein, E., Hooper, L. V., Baumler, A. J., & Winter, S. E. (2018). Precision editing of the gut microbiota ameliorates colitis. Nature, 553(7687), 208-211. https://doi.org/10.1038/nature25172 | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/90353 | - |
| dc.description.abstract | 精準醫療是一種將個體特徵納入治療規劃的個體化疾病預防、診斷和治療方式，期望透過準確辨識病因以規劃出最佳療程，達到改善健康狀態且降低醫療成本的目的。精準醫療經常透過精準營養領域與微生物相相互連結，將個體獨特的微生物群落組成、基因組和生活方式等因素綜合分析，協助個體維持最佳的健康狀態。異位性皮膚炎是一種慢性發炎性皮膚疾病，常見症狀有癢、紅腫、皮膚龜裂等，是常見的免疫疾病，影響全球約15-30%的兒童和10%的成人。研究指出腸道微生物相可能是引發異位性皮膚炎和影響疾病進程中的關鍵角色，針對腸道微生物相進行介入被認為是一種潛在的治療方式。本研究結果發現，在6個接受為期60天的益生菌治療的參與者中，有5個顯示出症狀改善，推測可歸因於腸道中益菌的增加，進而產生抗發炎的細胞激素和免疫細胞，同時降低了誘發發炎反應的免疫系統接收器靈敏度，和提升腸道屏障完整性。我們的研究結果支持了益生菌療法運用在治療異位性皮膚炎症狀的有效性，突顯了精準醫療和微生物相在異位性皮膚炎治療中的潛力，未來需要進一步的研究更深入瞭解微生物相與異位性皮膚炎之間複雜的相互作用，為更加精準和有效的治療方法鋪路。 | zh_TW |
| dc.description.abstract | Precision medicine is a medical approach that aims to personalize disease prevention, diagnosis, and treatment based on an individual's unique characteristics. Its objective is to enhance health outcomes and reduce healthcare costs by identifying and addressing the underlying causes of diseases, rather than merely addressing symptoms. Precision medicine and the microbiota are commonly linked through the emerging field of precision nutrition, which considers an individual's unique microbiota composition, genetic makeup, and lifestyle factors to optimize health outcomes. Atopic dermatitis is a chronic inflammatory skin disease that results in itchy, red, swollen, and cracked skin. It is a common condition that affects 15-30% of children and 10% of adults worldwide. Research has suggested that the gut microbiota may play a key role in the development and progression of atopic dermatitis, and that microbiota-targeted interventions may have potential for treating the condition. Canine atopic dermatitis has been found to be similar to human atopic dermatitis in several aspects, and the welfare of dogs is a rising concern. In our study, 5 out of 6 participants demonstrated improvement after receiving a 60-day probiotic treatment. This improvement can be attributed to the increase in beneficial bacteria in the intestine, leading to the production of anti-inflammatory cytokines and activation of immune cells. Additionally, the treatment resulted in the down-regulation of immune receptors and enhanced integrity of the gut barrier. Our findings support the effectiveness of microbiota-targeted treatments in alleviating atopic dermatitis symptoms in dogs. Overall, our study highlights the potential of precision medicine and microbiota-targeted interventions in managing atopic dermatitis. Further research is needed to deepen our understanding of the intricate interactions between the microbiota and atopic dermatitis, paving the way for more tailored and effective therapeutic approaches in the future. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-09-27T16:08:49Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2023-09-27T16:08:49Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 謝辭 i
中文摘要 ii ABSTRACT iii TABLE OF CONTENTS v LIST OF FIGURES vi LIST OF TABLES vii INTRODUCTION 1 BACKGROUND 3 PRECISION MEDICINE IN JAPAN, FRANCE, AND TAIWAN 3 MICROBIOTA TREATMENT IN PRECISION MEDICINE 5 MATERIALS AND METHODS 8 RESULTS 11 DISCUSSION 20 CONCLUSION AND A WAY FORWARD 25 REFERENCES 29 | - |
| dc.language.iso | en | - |
| dc.subject | 益生菌治療 | zh_TW |
| dc.subject | 精準醫療 | zh_TW |
| dc.subject | 微生物相 | zh_TW |
| dc.subject | 菌相分析 | zh_TW |
| dc.subject | 異位性皮膚炎 | zh_TW |
| dc.subject | probiotics treatment | en |
| dc.subject | precision medicine | en |
| dc.subject | atopic dermatitis | en |
| dc.subject | microbiota analysis | en |
| dc.subject | microbiota | en |
| dc.title | 探索微生物相在精準醫療的潛力—以犬異位性皮膚炎為例 | zh_TW |
| dc.title | Exploring the Potential of Microbiota in Precision Medicine – Taking Canine Atopic Dermatitis as an Example | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 111-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 劉嚞睿;王聖耀 | zh_TW |
| dc.contributor.oralexamcommittee | Je-Ruei Liu;Sheng-Yao Wang | en |
| dc.subject.keyword | 精準醫療,微生物相,菌相分析,益生菌治療,異位性皮膚炎, | zh_TW |
| dc.subject.keyword | precision medicine,microbiota,microbiota analysis,probiotics treatment,atopic dermatitis, | en |
| dc.relation.page | 35 | - |
| dc.identifier.doi | 10.6342/NTU202302175 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2023-07-27 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 國際三校農業生技與健康醫療碩士學位學程 | - |
| dc.date.embargo-lift | 2028-08-01 | - |
| 顯示於系所單位： | 國際三校農業生技與健康醫療碩士學位學程 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-111-2.pdf 未授權公開取用 | 1.28 MB | Adobe PDF | 檢視/開啟 |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。